258 related articles for article (PubMed ID: 17989545)
21. [Perioperative management of antiplatelet therapy in thoracic surgery. A survey of German hospitals].
Wiesemann S; Passlick B
Chirurg; 2012 Jun; 83(6):576-82. PubMed ID: 22327953
[TBL] [Abstract][Full Text] [Related]
22. [Antiplatelet agents and anticoagulants: management of the anticoagulated surgical patient].
Llau JV; Ferrandis R; López Forte C
Cir Esp; 2009 Jun; 85 Suppl 1():7-14. PubMed ID: 19589404
[TBL] [Abstract][Full Text] [Related]
23. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Aronow HD; Steinhubl SR; Brennan DM; Berger PB; Topol EJ;
Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647
[TBL] [Abstract][Full Text] [Related]
24. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
[TBL] [Abstract][Full Text] [Related]
25. Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding.
May AE; Geisler T; Gawaz M
Thromb Haemost; 2008 Mar; 99(3):487-93. PubMed ID: 18327396
[TBL] [Abstract][Full Text] [Related]
26. Effect of increased aspirin dose after stenting in association with ClOpidogrel: the FIASCO randomized study.
Cuisset T; Frere C; Quilici J; Uhry S; Morange PE; Mouret JP; Gaborit B; Bali L; Moro PJ; Lambert M; Bonnet JL
Thromb Res; 2009 May; 124(1):33-6. PubMed ID: 18990434
[TBL] [Abstract][Full Text] [Related]
27. Clopidogrel versus low-dose aspirin as risk factors for epistaxis.
Rainsbury JW; Molony NC
Clin Otolaryngol; 2009 Jun; 34(3):232-5. PubMed ID: 19531172
[TBL] [Abstract][Full Text] [Related]
28. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
29. Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbar anesthesia and vitreoretinal surgery.
Passemard M; Koehrer P; Juniot A; Bron AM; Creuzot-Garcher C
Retina; 2012 Oct; 32(9):1868-73. PubMed ID: 22495328
[TBL] [Abstract][Full Text] [Related]
30. [Recommendations for peri-procedural thrombocyte aggregation inhibition].
Sauer H; Leschke M
Dtsch Med Wochenschr; 2006 Feb; 131(8):400-2. PubMed ID: 16479474
[No Abstract] [Full Text] [Related]
31. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
Reaume KT; Regal RE; Dorsch MP
Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
[TBL] [Abstract][Full Text] [Related]
32. Management of patients with high gastrointestinal risk on antiplatelet therapy.
Cryer B
Gastroenterol Clin North Am; 2009 Jun; 38(2):289-303. PubMed ID: 19446259
[TBL] [Abstract][Full Text] [Related]
33. [Safety of aspirin, clopidogrel, and acenocumarol combination in patients requiring anticoagulation].
Sánchez-Torrijos J; Gudín-Uriel M; Ridocci-Soriano F
Rev Esp Cardiol; 2006 Dec; 59(12):1345-6. PubMed ID: 17194433
[No Abstract] [Full Text] [Related]
34. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
35. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
Duzenli MA; Ozdemir K; Aygul N; Soylu A; Tokac M
Am J Cardiol; 2008 Aug; 102(4):396-400. PubMed ID: 18678294
[TBL] [Abstract][Full Text] [Related]
36. Lower aspirin doses in dual antiplatelet therapy optimise efficacy and safety: CHARISMA follow-up study.
Cardiovasc J Afr; 2009; 20(3):205. PubMed ID: 19575092
[No Abstract] [Full Text] [Related]
37. Management of upper gastrointestinal haemorrhage complicating dual anti-platelet therapy.
Henriksen PA; Palmer K; Boon NA
QJM; 2008 Apr; 101(4):261-7. PubMed ID: 18252776
[TBL] [Abstract][Full Text] [Related]
38. Aspirin, clopidogrel, and the surgeon.
Patel PA; Fleisher LA
Adv Surg; 2014; 48():211-22. PubMed ID: 25293617
[TBL] [Abstract][Full Text] [Related]
39. Dual antiplatelet drug resistance in patients with acute coronary syndrome.
Guha S; Sardar P; Guha P; Roy S; Mookerjee S; Chakrabarti P; Deb PK; Chaudhuri U; Deb S; Karmakar R; Dasgupta AK; Lahiri P
Indian Heart J; 2009; 61(1):68-73. PubMed ID: 19729693
[TBL] [Abstract][Full Text] [Related]
40. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
Mohler ER
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
